The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

Author(s):
Engels, C.C.; Charehbili, A.; Velde, C.J.H. van de (0000-0003-0104-1800); Bastiaannet, E.; Sajet, A.; Putter, H.; Vliet, E.A. van; Vlierberghe, R.L.P. van (0000-0003-0897-8049); Smit, V.T.H.B.M. (0000-0003-3730-5652); Bartlett, J.M.S.; Seynaeve, C.; Liefers, G.J.; Kuppen, P.J.K. (0000-0002-0294-3251)
Published
2015
Publication type
Article / Letter to editor
Breast cancerAdjuvant endocrine therapyTumor immune subtypesPrognostic and predictive value
Date issued
2015-02-28
Language
English
Is part of
Breast Cancer Research and Treatment (2015), Vol. 149, no. 3, p. 587-596
hdl
1887/108350
doi
10.1007/s10549-015-3269-7